Evidence map›Paper›PMID 40806394›Full record

ArticleInternational journal of molecular sciences2025

Luminescent Properties and Cytotoxic Activity of 2-phenylbenzoxazole Fluorosulfate Derivatives.

Nadezhda V Danilenko, Mariia O Lutsuk, Alexey A Ryadun, Dmitry I Pavlov, Evgenii V Plotnikov, Daria D Eskova, Yulia D Klimenko, Andrei S Potapov, Andrei I Khlebnikov

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nadezhda V DanilenkoKizhner Research Center, Tomsk Polytechnic University, 634050 Tomsk, Russia.
Mariia O LutsukKizhner Research Center, Tomsk Polytechnic University, 634050 Tomsk, Russia.
Alexey A RyadunNikolaev Institute of Inorganic Chemistry, Siberian Branch of the Russian Academy of Sciences, 3 Lavrentiev Ave., 630090 Novosibirsk, Russia.
Dmitry I PavlovNikolaev Institute of Inorganic Chemistry, Siberian Branch of the Russian Academy of Sciences, 3 Lavrentiev Ave., 630090 Novosibirsk, Russia.ORCID 0000-0002-5996-8062
Evgenii V PlotnikovResearch School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Avenue, 634034 Tomsk, Russia.ORCID 0000-0002-4374-6422
Daria D EskovaResearch School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Avenue, 634034 Tomsk, Russia.ORCID 0009-0000-4945-1257
Yulia D KlimenkoResearch School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Avenue, 634034 Tomsk, Russia.
Andrei S PotapovNikolaev Institute of Inorganic Chemistry, Siberian Branch of the Russian Academy of Sciences, 3 Lavrentiev Ave., 630090 Novosibirsk, Russia.ORCID 0000-0003-2360-7473
Andrei I KhlebnikovKizhner Research Center, Tomsk Polytechnic University, 634050 Tomsk, Russia.ORCID 0000-0002-3022-4510

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of 2-phenylbenzoxazole fluorosulfate derivatives was carried out using the SuFEx reaction. To study the anticancer properties of the obtained compounds, the cell lines PC-3 (obtained from prostate adenocarcinoma), BT-474, and MCF-7 (both obtained from breast carcinoma) were used. The cytotoxicity on murine 3T3L1 embryonic was also investigated. Among the tested compounds, the

Indexed as

Antineoplastic AgentsBenzoxazolesAnimalsCell Line, TumorCell ProliferationHumansMCF-7 CellsMiceMolecular Docking SimulationAntineoplastic AgentsBenzoxazolesantitumor activitybenzoxazolefluorescenceSuFEx

Identifiers

PMID40806394
PMCPMC12347133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.